Cancer Drugs: The High Cost of a 'Ticket' to Survival

The landscape of cancer treatment in Vietnam is evolving, marked by a significant increase in patient numbers and a growing reliance on advanced therapies, yet underscored by the persistent challenge of drug affordability. At Cho Ray Hospital, the number of cancer patients treated has surged by 42% over the past five years, with a particularly sharp rise of over 73% in chemotherapy treatments, reflecting the growing burden of the disease.

“

The number of cancer patients treated at the hospital has increased by 42% after five years.

While cutting-edge treatments like immunotherapy and targeted therapies come with hefty price tags, experts stress that they are not always the most suitable or accessible option for every patient. Dr. Lê Tuấn Anh, Director of the Oncology Center at Cho Ray Hospital, explains that most patients utilize drugs covered by health insurance (BHYT), which significantly alleviates financial strain. Only a small percentage of patients can afford or are suitable for expensive newer drugs, which require strict indications and are not universally applicable.

Dr. Tuấn Anh emphasizes that cancer treatment is a comprehensive, long-term journey requiring multidisciplinary consultation to develop a personalized plan. This plan encompasses surgery, chemotherapy, radiation therapy, immunotherapy, or targeted drugs, tailored to the individual's condition. Patients need a clear understanding of the entire treatment process, including financial planning, treatment location, and logistical arrangements.

“

Most cancer patients use drugs covered by health insurance (BHYT), significantly reducing the financial burden.

Furthermore, the suitability of targeted and immunotherapy drugs depends on specific criteria, such as the presence of appropriate gene mutations. Even with financial means, patients may not be candidates if their genetic profile doesn't match the drug's requirements. Doctors must present various options, allowing patients to make informed decisions based on efficacy, cost, and their overall health status. Factors like liver or kidney function can influence treatment choices, sometimes necessitating a shift to alternative therapies even if a patient could afford the best option.

“

The number of patients using expensive new drugs like immunotherapy or targeted drugs only accounts for a small percentage, as these drugs have strict indications and are not suitable for all cases.

Dr. Võ Đức Hiếu, Deputy Director of Ho Chi Minh City Oncology Hospital, notes the increasing diversity and specialization of cancer drugs available in Vietnam, extending beyond traditional chemotherapy and hormonal therapies to include more advanced agents. The challenge remains ensuring these advanced treatments are accessible and affordable for a wider patient population, highlighting the crucial role of health insurance and ongoing efforts to expand its coverage for cancer medications.

“

Cancer treatment is a comprehensive process that requires multidisciplinary consultation to build a suitable plan, including the cost of the entire treatment process.